Long-term treatment outcome in chronic myeloid leukemia patients in accelerated phase treated with imatinib (glevec®)

Long-term treatment outcome in chronic myeloid leukemia patients in accelerated phase treated with imatinib (glevec®)

The purpose of this study was evalueted of a long-term treatment outcome in chronic myeloid leukemia (CML) patients in accelerated phase treated with GlivecR and determination of an optimum therapy schedule. 105 patients (men — 46, women — 59) at the age from 15 till 74 years (a median age — 40 year...

Full description

Saved in:
Bibliographic Details
Main Authors: L. A. Antipova, S. S. Loria, S. V. Semochkin, A. G. Rumiantsev
Format: Article
Language:Russian
Published: ABV-press 2022-11-01
Series:Онкогематология
Subjects:
chronic myeloid leukemia
acceleration phase
imatinib
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/705
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items